Menu

Accelerating Cell-free Transcription & Translation with Acoustic Liquid Handling

Labcyte invites you to join them for an educational webinar on cell-free TXTL, featuring researchers from the University of Minnesota.

Jun 11, 2018
The Scientist Creative Services Team

Accelerating Cell-free Transcription & Translation with Acoustic Liquid Handling from thescientistllc on Vimeo.

Cell-free transcription-translation (TXTL) is becoming a popular laboratory research tool covering a growing number of multidisciplinary applications. TXTL is employed in biology, bioengineering, synthetic biology, and biological physics. Major applications of TXTL include biomanufacturing and prototyping DNA programs, from regulatory elements to gene circuits. The new generation of TXTL systems is user-friendly, powerful, and versatile. Combined with automated liquid dispensing, TXTL can dramatically accelerate bioengineering and the characterization of novel technologies, such as CRISPR. Labcyte, Inc., the sponsor of this LabTools webinar, provides a unique, automated acoustic liquid handler ideal for TXTL work.

Topics to be covered:

  • Review of the available TXTL platforms and their capabilities
  • The major TXTL applications
  • High-throughput TXTL reactions using the Echo 550 Liquid Handler from Labcyte

Meet the Speakers: 

Vincent Noireaux, PhD
Professor
University of Minnesota


Ryan Marshall
Graduate Student
University of Minnesota


Alex Pierson
Field Application Scientist
Labcyte


January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.